InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Friday, 01/27/2017 5:21:52 PM

Friday, January 27, 2017 5:21:52 PM

Post# of 807
we forecast at least $1bn WW peak sales for £65-75m income to OXB (Oxford BioMedica) p.a. providing an important sustainable revenue stream for c.5p/share NPV at 80% probability, more than underpinning the current share price.”

https://endpts.com/fighting-a-generic-onslaught-novartis-adds-car-t-to-its-growing-list-of-late-stage-blockbusters/